Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

Semaglutide is linked to a reduced risk for Alzheimer’s disease-related dementia in patients with diabetes vs other antidiabetic drugs, a new study suggests.

A recent surge in misleading ads and AI-generated videos on social media and other online sites, promoting bogus diabetes ...

A new study published in JAMA Internal Medicine introduces the DASH4D diet—a modified DASH plan tailored for people with type ...

Beyond helping diabetes patients lose weight and control blood sugar, semaglutide appears to cut dementia risk by nearly half ...

Weight-loss drugs offer initial benefits but often lead to weight regain after discontinuation. Bariatric surgery provides ...

Combining physician education with patient previsit activation increases deprescribing of diabetes medications, according to ...

A study may have found a cure for type 1 diabetes. Here, experts explain how the treatment, zimislecel, works and what it ...

A lower-sodium Dietary Approaches to Stop Hypertension-style diet was associated with clinically meaningful BP reduction in ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

Discover 8 effective ways to manage diabetes naturally. Learn lifestyle changes that reduce medication dependency and improve ...

Among the four diet types trialed in this study, a modified version of the DASH diet with reduced sodium intake achieved a ...